Histopathological Study of Non-Cirrhotic Portal Fibrosis (NCPF) With Special Emphasis on Advanced Fibrosis

Authors

  • Rachana Chaturvedi Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai
  • Tejal Shah Seth G.S. Medical College & KEM Hospital, Mumbai
  • Amita Joshi Seth G.S. Medical College & KEM Hospital, Mumbai
  • Toshi Mishra Seth G.S. Medical College & KEM Hospital, Mumbai
  • Manjusha Karegar Seth G.S. Medical College & KEM Hospital, Mumbai
  • Akash Shukla Seth G.S. Medical College & KEM Hospital, Mumbai

DOI:

https://doi.org/10.21276/apalm.2358

Keywords:

PHT, NCPF, EHPVO, phlebosclerosis, portal tract fibrosis

Abstract

Background: Non-cirrhotic portal hypertension includes primarily the cases of non-cirrhotic portal fibrosis (NCPF) and extra-hepatic portal vein obstruction, both showing no significant parenchymal disease. NCPF is a disease of uncertain etiology characterized by periportal fibrosis with small and medium sized portal vein branches involvement. Most study done in the past are clinical, hence we decided to analyse its histo-pathological features with clinical correlation.

Methods: This is four and half year’s retrospective study of liver biopsies of clinically diagnosed patients of NCPF. Fifteen patients of EHPVO served as controls. Biopsies were stained with Haematoxylin and eosin, reticulin and Masson’s trichrome.

Result: Total 978 benign specimens (excluding space-occupying lesions) received, of which 45 diagnosed as NCPF (4.6%). Most patients (68.88%) were between 20-40 years (M:F ratio 1:1.5), commonest symptoms long-standing splenomegaly (95%), anemia (78%) and variceal bleeds (42%) with duration varying from 3 months to 11 years. Commonest histopathological findings were portal tract fibrosis (77.78%), phlebosclerosis (68.89%), portal tract remnants (24.44%), more frequently seen in NCPF than EHPVO, septal fibrosis was seen in five. Follow up available in 91.11% cases showed no mortality or liver failure, but significant morbidity due to repeated episodes of variceal bleeds and hypersplenism.

Conclusion: NCPF is still common in India. Distinctive features on histology are portal tract fibrosis, portal tract remnants, with phlebosclerosis which is being statistically significant when comparing with EHPVO. NCPF can show advanced fibrosis, can also present with features of decompensation mimicking cirrhosis, however its course remains stable with good long-term survival.

Author Biographies

Rachana Chaturvedi, Seth G.S. Medical College and K.E.M. Hospital, Parel, Mumbai

Department of Pathology, Associate Professor

Tejal Shah, Seth G.S. Medical College & KEM Hospital, Mumbai

Department of pathology

Amita Joshi, Seth G.S. Medical College & KEM Hospital, Mumbai

Department of Pathology

Toshi Mishra, Seth G.S. Medical College & KEM Hospital, Mumbai

Department of Pathology

Manjusha Karegar, Seth G.S. Medical College & KEM Hospital, Mumbai

Department of Pathology

Akash Shukla, Seth G.S. Medical College & KEM Hospital, Mumbai

Department of Gastroenterology

References

[1] Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology 2008;134: 1715 -1728.
[2] Sarin SK, Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis 2006;10: 627-651.
[3] Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W et al. Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007;1: 398 - 413.
[4] Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis 2002; 22: 43 - 58.
[5] Garcia-Pagan JC, Hernandez-Guerra M, Bosch J. Extrahepatic portal vein thrombosis. Semin Liver Dis 2008; 28: 282 - 292.
[6] Yachha SK. Portal hypertension in children: an Indian perspective. J Gastroenterol Hepatol 2002; 17: S228–S231.
[7] Poddar U, Thapa BR, Rao KL, Singh K. Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West? J Gastroenterol Hepatol 2008; 23:1354 - 1357.
[8] Sarin SK, Sollano JD, Chawla YK, Amarapurkar D, Hamid S, Hashizume M. et al. Members of the APASL working party on portal hypertension. Consensus on extra-hepatic portal vein obstruction. Liver Int 2006; 26: 512 - 519.
[9] Schouten JNL, Garcia-Pagan JC, Valla DC, Janssen HLA. Idiopathic noncirrhotic portal hypertension.Hepatology 2011; 54:1071 - 1081.
[10] Dhiman RK, Chawla Y, Vasishta RK et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002;17: 6 - 16.
[11] Nayak NC, Ramalingaswami B. Obliterative portal venopathy of the liver. Arch Pathol Med 1969; 87: 359 - 369.
[12] Aoki H, Hasumi A, Yoshida K. A questionnaire study on treatment of idiopathic portal hypertension and extrahepatic portal obstruction. In: Kameda H, editor. Annual report on portal portal hemodynamics abnormalities (in Japanese). Tokyo: Japan Ministry of Health and Welfare; 1988: 179 - 189.
[13] Verheij J, Schouten JNL, Komuta M, Nevens F, Hansen BE, et al. Histological features in western patients with idiopathic non-cirrhotic portal hypertension. J Histopathol. 2013; 62:1083 -1091.
[14] Vakili C, Farahvash MJ, Bynum TE. Endemic idiopathic portal hypertension. Report on 32 patients with non-cirrhotic portal fibrosis. World J Surg 1992;16:118 - 125.
[15] Sarin SK, Agarwal SR. Idiopathic portal hypertension. Digestion 1998; 59: 420 - 423.
[16] Pande C, Kumar A, Sarin SK. Non-cirrhotic portal fibrosis: a clinical profile of 366 patients. Am J Gastroenterol 2006;101:191.
[17] Madhu K, Avinash B, Ramakrishna B, Eapen CE, Shyamkumar NK et al. Idiopathic non-cirrhotic intrahepatic portal hypertension: common cause of cryptogenic intrahepatic portal hypertension in a Southern Indian tertiary hospital. Indian J Gastroenterol 2009; 28: 83 - 87.
[18] Sarin SK. Non-cirrhotic portal fibrosis. J Gastroenterol Hepatology. 2002; 17: S214 - S223.
[19] Bernard PH, Le Bail B, Cransac M et al. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J. Hepatol. 1995; 22: 495 - 499.
[20] Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et a. Histological grading and staging of chronic hepatitis. J Hepatol. 1995 Jun; 22: 696 - 699.
[21] Kunio Okuda, Toshiro Nakashima, Masahiko Okudaira, Masayoshi Kage, Yoshifumi Aida, Masao Omata et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. Liver 1982; 2: 176 -192.
[22] Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 2001; 197: 65–76.
[23] Okudaria M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis 2002; 22: 59–71.
[24] Baldus WP. Idiopathic portal hypertension: a histopathologic study of 26 Japanese cases. Histopathology 1993; 22: 227-34.
[25] Sciot R, Staessen D, Van Damme B et al. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988; 13: 593 - 603.
[26] Nevens F, Staessen D, Sciot R et al. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology 1994; 106: 459 - 63.
[27] James M. Crawford. Cirrhosis. In: Robert D. Odze and John R. Goldblum editors. Surgical Pathology of GI Tract, Liver, Biliary Tract and Pancreas, 3rd edition. SAUNDERS, an imprint of Elsevier Inc. Lmt.; 1978 - 79.
[28] Petrelli M, Scheuer PJ. Variation in subcapsular liver structure and its significance in the interpretation of wedge biopsies. J Clin Pathol, 1967; 20: 743 - 748.
[29] Hillaire S, Bonte E, Denninger MH et al. Idiopathic non-cirrhostic intrahepatic portal hypertension in the west: a re-evaluation in 28 patients. Gut 2002; 51: 275 - 80.
[30] Madhu K, Ramakrishna B, Zachariah U, Eapen CE, Kurian G. Non-cirrhotic intrahepatic portal hypertension. Gut 2008; 57:152 - 9.
[31] Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic non-cirrhotic portal hypertension. Liver Transpl 2005; 11: 627- 34.
[32] Sarin SK, Kappor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 2002; 17: 526 - 34.
[33] Khanna R, Sarin SK. Non-cirrhotic portal hypertension – Diagnosis and management. Journal of Hepatology 2014; 60:421–441

Downloads

Published

27-12-2018

How to Cite

1.
Chaturvedi R, Shah T, Joshi A, Mishra T, Karegar M, Shukla A. Histopathological Study of Non-Cirrhotic Portal Fibrosis (NCPF) With Special Emphasis on Advanced Fibrosis. Ann of Pathol and Lab Med [Internet]. 2018 Dec. 27 [cited 2024 Dec. 27];5(12):A1002-1008. Available from: https://pacificejournals.com/journal/index.php/apalm/article/view/2358

Issue

Section

Original Article